Robert A. Izydore

402 total citations
37 papers, 315 citations indexed

About

Robert A. Izydore is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Robert A. Izydore has authored 37 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Organic Chemistry and 8 papers in Infectious Diseases. Recurrent topics in Robert A. Izydore's work include Biochemical and Molecular Research (12 papers), HIV/AIDS drug development and treatment (8 papers) and Click Chemistry and Applications (5 papers). Robert A. Izydore is often cited by papers focused on Biochemical and Molecular Research (12 papers), HIV/AIDS drug development and treatment (8 papers) and Click Chemistry and Applications (5 papers). Robert A. Izydore collaborates with scholars based in United States. Robert A. Izydore's co-authors include Oi T. Wong, Iris H. Hall, Robert G. Ghirardelli, Betsy Barnes, Bernard F. Spielvogel, Ann E. Eakin, Bernard T. Gillis, Samuel A. McLean, I.H. Hall and Mia Miller and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Robert A. Izydore

35 papers receiving 308 citations

Peers

Countries citing papers authored by Robert A. Izydore

Since Specialization

Citations

This map shows the geographic impact of Robert A. Izydore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Izydore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Izydore more than expected).

Fields of papers citing papers by Robert A. Izydore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Izydore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Izydore. The network helps show where Robert A. Izydore may publish in the future.

Co-authorship network of co-authors of Robert A. Izydore

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Izydore. A scholar is included among the top collaborators of Robert A. Izydore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Izydore. Robert A. Izydore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alvaradoins E−N, Antitumor and Cytotoxic Anthracenone C-Glycosides from the Leaves of Alvaradoa haitiensis 2007 ·Journal of Natural Products ·(unknown), Dongho Lee, Eun Kyoung Seo, (unknown), Tyler N. Graf, David J. Kroll, Hernán A. Navarro, Robert A. Izydore, F. Agustín Jiménez, Ricardo Garcı́a, William C. Rose, Craig R. Fairchild, Robert Wild, Djaja D. Soejarto, Norman R. Farnsworth, A. Douglas Kinghorn, Nicholas H. Oberlies, Monroe E. Wall, Mansukh C. Wani	24
2	Implications of selective type II IMP dehydrogenase (IMPDH) inhibition by the 6-ethoxycarbonyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones on tumor cell death22Abbreviations: IMPDH, IMP dehydrogenase; MPA, mycophenolic acid; 6-MP, 6-mercaptopurine; and VP-16, etoposide. 2001 ·Biochemical Pharmacology ·Betsy Barnes, Ann E. Eakin, Robert A. Izydore, (unknown)	8
3	Tmolt4 Leukemic Type II Isoform of IMP Dehydrogenase as a Target for 1,2,4-Triazolidine-3,5-diones, 1-(1-(3-Methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-Isoxazolidinediones, and 4,4-Disubstituted-3,5-pyrazolidinediones 2001 ·Archiv der Pharmazie ·Iris H. Hall, (unknown), (unknown), (unknown), (unknown), Robert A. Izydore	5
4	Cytotoxicity of 2-ethenyl-2,3-dihydrophthalazine-1,4-diones in murine and human tumor cultured cells. 2001 ·PubMed ·I.H. Hall, (unknown), (unknown), Robert A. Izydore, Xiaoming Zhou	2
5	Induction of Tmolt4 Leukemia Cell Death by 3,3-Disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2,4-diones: Specificity for Type II Inosine 5′-Monophosphate Dehydrogenase 2001 ·Journal of Pharmacology and Experimental Therapeutics ·Betsy Barnes, Robert A. Izydore, Ann E. Eakin, Iris H. Hall	1
6	Mechanism of action of the antitumor agents 6-benzoyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones: Potent inhibitors of human type II inosine 5?-monophosphate dehydrogenase 2001 ·International Journal of Cancer ·Betsy Barnes, Robert A. Izydore, Ann E. Eakin, (unknown)	5
7	Analysis of the in vitro inhibition of murine and human tumor cell growth by pyrazole derivatives and a substituted azabicyclo [3.1.0] hexane-2,4-dione. 2001 ·PubMed ·Betsy Barnes, Robert A. Izydore, Iris H. Hall	5
8	Synthesis and Cytotoxic Action of 1-Oxoalkyl and 1,2-Dioxoalkyl-1,2,4-triazolidine-3,5-diones in Murine and Human Tissue Cultured Cells 1999 ·Archiv der Pharmazie ·(unknown), Iris H. Hall, Robert A. Izydore	7
9	Synthesis and Cytotoxic Action of 3,5‐Isoxazolidinediones and 2‐Isoxazolin‐5‐ones in Murine and Human Tumors 1997 ·Archiv der Pharmazie ·Iris H. Hall, Robert A. Izydore, (unknown), (unknown), (unknown), Manik L. Debnath, (unknown), (unknown)	9
10	Structure and Conformations of Monoacyl and Diacyl 1,2,4-Triazolidine-3,5-diones 1996 ·The Journal of Organic Chemistry ·Robert A. Izydore, Anthony A. Ribeiro, Iris H. Hall	2
11	Investigation of 3,5-Isoxazolidinediones as Hypolipidemic Agents in Rodents 1995 ·Pharmaceutical Research ·(unknown), Manik L. Debnath, (unknown), Robert A. Izydore, (unknown), Oi T. Wong, (unknown), (unknown)	9
12	Structure Activity Relationships of 4‐Substituted 1‐Acyl and 1,2‐Diacyl‐1,2,4‐triazolidine‐3,5‐diones as Anti‐inflammatory Agents in Rodents 1995 ·Archiv der Pharmazie ·Iris H. Hall, (unknown), Robert A. Izydore	4
13	Hypolipidemic Activity of 4-Substituted 1,2-Diacyl-1,2,4-triazolidine-3,5-diones in Rodents 1994 ·Journal of Pharmaceutical Sciences ·(unknown), Oi T. Wong, Iris H. Hall, Robert A. Izydore	22
14	The Hypolipidemic Effects of l-Acetyl-4-phenyl-l,2,4-triazolidine-3,5-dione in Rodents 1993 ·Pharmaceutical Research ·Iris H. Hall, (unknown), Patricia M. Day, Oi T. Wong, (unknown), Robert A. Izydore	5
15	Synthesis and Hypolipidemic Activity of 4-Substituted 1-Acyl-1,2,4-Triazolidine-3,5-diones in Rodents 1993 ·Journal of Pharmaceutical Sciences ·(unknown), Robert A. Izydore, Oi T. Wong, (unknown)	19
16	The antineoplastic and cytotoxicity of benzohydroxamic acids and related derivatives in murine and human tumor cells 1992 ·Anti-Cancer Drugs ·(unknown), Robert A. Izydore, (unknown), (unknown), (unknown), Manik L. Debnath, (unknown)	4
17	Potential aldose reductase inhibitors: 1,2,4-triazolidine-3,5-diones and 2-(3,4,5-trimethoxybenzoyl)-4,4-diethyl-3,5-isoxazolidinedione 1992 ·Cellular and Molecular Life Sciences ·I.H. Hall, Robert A. Izydore, (unknown), Oi T. Wong	4
18	Hypolipidemic activity of aliphatic dicarboxylic acids in rodents. 1991 ·PubMed ·Robert A. Izydore, (unknown)	3
19	2,3-Dimethylcyclopropanecarboxylic acids from 2,3-dimethyloxirane via the Wittig reaction. Stereochemistry and mechanism 1973 ·The Journal of Organic Chemistry ·Robert A. Izydore, Robert G. Ghirardelli	21
20	Stability, decomposition, and reactivity of a 1,2-diazacyclopentene 3,5-dione. 4,4-Diethylpyrazoline-3,5-dione 1969 ·The Journal of Organic Chemistry ·Bernard T. Gillis, Robert A. Izydore	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact